Literature DB >> 28325144

Therapeutic Potential and Outlook of Alternative Medicine for Osteoporosis.

Tao Wang1,2, Qian Liu1,2,3, William Tjhioe3, Jinmin Zhao1,2, Aiping Lu4, Ge Zhang4, Ren Xiang Tan5, Mengyu Zhou6, Jiake Xu2,3, Hao Tian Feng2,3.   

Abstract

Osteoporosis, a bone disease resulting in the loss of bone density and microstructure quality, is often associated with fragility fractures, and the latter imposes a great burden on the patient and society. Although there are several different treatments available for osteoporosis such as hormone replacement therapy, bisphosphonates, Denosumab, and parathyroid hormone, some concerns have been raised regarding the inherent side effects of their long term use. It would be of great relevance to search for alternative natural compounds, which could complementarily overcome the limitations of the currently available therapy. Herein, we review current literature on natural compounds that might have therapeutic values for osteoporosis. Search terms included bone resorption, bone density, osteoporosis, postmenopausal, osteoporosis or bone density conservation agents, and any of the terms related to traditional, herbal, natural therapy, natural health, diet, or phytoestrogens. All the compounds and herbs included in the review are naturally bioactive or are used in folk herbal medicine and have been reported to be capable of attenuating osteopenia or osteoporosis in vivo or in vitro, through various mechanisms - estrogen-like activity, antioxidant and anti-inflammatory properties, or by modulating the key signaling pathways in the pathogenesis of osteoporosis. Through our assessment of the therapeutic potential and outlook of alternative medicine, we aim to provide an appealing perspective for the consideration of the application of a complementary anti-osteoporotic treatment option and prevention strategy for osteoporosis or osteolytic bone disorders. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Herbal medicine; natural compounds; osteoblast; osteoclast; osteoporosis; postmenopausal osteoporosis

Mesh:

Substances:

Year:  2017        PMID: 28325144     DOI: 10.2174/1389450118666170321105425

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  33 in total

1.  Hesperetin alleviated glucocorticoid-induced inhibition of osteogenic differentiation of BMSCs through regulating the ERK signaling pathway.

Authors:  Ling Liu; Jie Zheng; YaZhen Yang; Lingjuan Ni; Hongyu Chen; Dongrong Yu
Journal:  Med Mol Morphol       Date:  2020-04-06       Impact factor: 2.309

Review 2.  Bone regeneration in osteoporosis: opportunities and challenges.

Authors:  Dhrumi Patel; Sarika Wairkar
Journal:  Drug Deliv Transl Res       Date:  2022-08-22       Impact factor: 5.671

Review 3.  Traditional Chinese Medicine as a Promising Strategy for the Treatment of Alzheimer's Disease Complicated With Osteoporosis.

Authors:  Weifan Xu; Yiping Jiang; Nani Wang; Huanhuan Bai; Shengyan Xu; Tianshuang Xia; Hailiang Xin
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

4.  Editorial: Bone and Cartilage Diseases-The Role and Potential of Natural Products.

Authors:  Daohua Xu; Longhuo Wu; Qian Chen
Journal:  Front Pharmacol       Date:  2022-05-26       Impact factor: 5.988

5.  Sal B targets TAZ to facilitate osteogenesis and reduce adipogenesis through MEK-ERK pathway.

Authors:  Na Wang; Yukun Li; Ziyi Li; Chang Liu; Peng Xue
Journal:  J Cell Mol Med       Date:  2019-03-25       Impact factor: 5.310

6.  Anti-Osteoporotic Effects of Commiphora Myrrha and Its Poly-Saccharide via Osteoclastogenesis Inhibition.

Authors:  Youn-Hwan Hwang; Ami Lee; Taesoo Kim; Seon-A Jang; Hyunil Ha
Journal:  Plants (Basel)       Date:  2021-05-10

Review 7.  Pharmacological activities of ginsenoside Rg5 (Review).

Authors:  Ming-Yang Liu; Fei Liu; Yan-Li Gao; Jia-Ning Yin; Wei-Qun Yan; Jian-Guo Liu; Hai-Jun Li
Journal:  Exp Ther Med       Date:  2021-06-06       Impact factor: 2.447

8.  Patchouli Alcohol Modulates the Pregnancy X Receptor/Toll-like Receptor 4/Nuclear Factor Kappa B Axis to Suppress Osteoclastogenesis.

Authors:  Qian Lu; Chao Jiang; Jialong Hou; Hao Qian; Feifan Chu; Weiqi Zhang; Mengke Ye; Ziyi Chen; Jian Liu; Hanbing Yao; Jianfeng Zhang; Jiake Xu; Te Wang; Shunwu Fan; Qingqing Wang
Journal:  Front Pharmacol       Date:  2021-06-08       Impact factor: 5.810

9.  Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis.

Authors:  Zezheng Liu; Wenquan Liang; Dawei Kang; Qingjing Chen; Zhicong Ouyang; Huibo Yan; Bin Huang; Dadi Jin; Yinkui Chen; Qingchu Li
Journal:  Clin Interv Aging       Date:  2020-07-20       Impact factor: 4.458

10.  Madecassoside inhibits estrogen deficiency-induced osteoporosis by suppressing RANKL-induced osteoclastogenesis.

Authors:  Qingqing Wang; Lingya Yao; Ke Xu; Haiming Jin; Kai Chen; Ziyi Wang; Qian Liu; Zhen Cao; Jacob Kenny; Yuhao Liu; Jennifer Tickner; Huazi Xu; Jiake Xu
Journal:  J Cell Mol Med       Date:  2018-10-19       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.